Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan 24;12(2):287.
doi: 10.3390/cancers12020287.

Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers

Affiliations
Review

Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers

Ha Thi Thu Do et al. Cancers (Basel). .

Abstract

Chemokines are chemotactic cytokines that mediate immune cell chemotaxis and lymphoid tissue development. Recent advances have indicated that chemokines and their cognate receptors play critical roles in cancer-related inflammation and cancer progression. On the basis of these findings, the chemokine system has become a new potential drug target for cancer immunotherapy. In this review, we summarize the essential roles of the complex network of chemokines and their receptors in cancer progression. Furthermore, we discuss the potential value of the chemokine system as a cancer prognostic marker. The chemokine system regulates the infiltration of immune cells into the tumor microenvironment, which induces both pro- and anti-immunity and promotes or suppresses tumor growth and proliferation, angiogenesis, and metastasis. Increasing evidence indicates the promising prognostic value of the chemokine system in cancer patients. While CCL2, CXCL10, and CX3CL1/CX3CR1 can serve as favorable or unfavorable prognostic factors depending on the cancer types, CCL14 and XCL1 possess good prognostic value. Other chemokines such as CXCL1, CXCL8, and CXCL12 are poor prognostic markers. Despite vast advances in our understanding of the complex nature of the chemokine system in tumor biology, knowledge about the multifaceted roles of the chemokine system in different types of cancers is still limited. Further studies are necessary to decipher distinct roles within the chemokine system in terms of cancer progression and to validate their potential value in cancer prognosis.

Keywords: angiogenesis; cancer; chemokines; immune cell recruitment; metastasis; prognostic marker; tumor growth and proliferation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Multifaceted roles of chemokines and their receptors in immune cell recruitment, tumor growth and proliferation, angiogenesis, and metastasis. Chemokines guide the trafficking of different immune cells expressing their respective receptors into the tumor microenvironment, which induces both anti- and protumor immunity. Additionally, the chemokine system generally stimulates tumor growth and proliferation. Chemokines can also regulate angiogenesis with their angiogenic or angiostatic functions. Furthermore, chemokines are involved in tumor migration to secondary sites to develop metastasis. CTL, CD8+ cytotoxic T lymphocyte; Th1, T helper cell; NK, natural killer cell; Treg, regulatory T cell; B, B cell; iDC, immature dendritic cells; mDC, mature dendritic cell; N, neutrophil, M, macrophage; MDSC, myeloid-derived suppressor cell. The purple arrows show the promotion of tumor growth and proliferation. The red arrows indicate the angiogenic effect. The red T line indicates the angiostatic effect. The green arrows indicate the promotion of metastasis. (For detailed information, please see the text.).

References

    1. Vinay D.S., Ryan E.P., Pawelec G., Talib W.H., Stagg J., Elkord E., Lichtor T., Decker W.K., Whelan R.L., Kumara H.S., et al. Immune evasion in cancer: Mechanistic basis and therapeutic strategies. Semin. Cancer Biol. 2015;35:S185–S198. doi: 10.1016/j.semcancer.2015.03.004. - DOI - PubMed
    1. Foxman E.F., Kunkel E.J., Butcher E.C. Integrating conflicting chemotactic signals. The role of memory in leukocyte navigation. J. Cell Biol. 1999;147:577–588. doi: 10.1083/jcb.147.3.577. - DOI - PMC - PubMed
    1. Foxman E.F., Campbell J.J., Butcher E.C. Multistep navigation and the combinatorial control of leukocyte chemotaxis. J. Cell Biol. 1997;139:1349–1360. doi: 10.1083/jcb.139.5.1349. - DOI - PMC - PubMed
    1. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature. 2008;454:436. doi: 10.1038/nature07205. - DOI - PubMed
    1. Bose S., Cho J. Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases. Arch. Pharmacal. Res. 2013;36:1039–1050. doi: 10.1007/s12272-013-0161-z. - DOI - PubMed